Skip to content
GenBioPro
  • Home
  • This field is for validation purposes and should be left unchanged.

logo-retina-1000-genbiopro

Putting Access Into Practice

© 2023 GenBioPro All Rights Reserved

Company

  • Important Safety Information Provider
  • Prescribing Information
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • STATEMENT REGARDING COMPLIANCE WITH CALIFORNIA HEALTH & SAFETY CODE § 119402

PROVIDERS

  • About Mifepristone
  • Prescribing
  • Ordering
  • Provider Resources
  • About GenBioPro

PATIENTS

  • About Medical Abortion
  • Taking Mifepristone
  • Community
  • Patient Resources
  • About GenBioPro

Health Care Provider Update

The US Food & Drug Administration (FDA) has communicated that it is exercising discretion to suspend enforcement of in-person dispensing requirements and in-person requirements related to the mifepristone Patient Agreement Form, provided other requirements are met.

To learn more about options for mail delivery to patients requiring mifepristone 200mg tablets, contact us.